Effect of cisplatin exposure on the degree of N-myc amplification in small cell lung carcinoma cell lines with N-myc amplification

Oncology (Switzerland)

Volumn 53, Issue 5, 1996, Pages 417-421

  Mizushima, Y ^a   Kashii, T ^a   Kobayashi, M ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Amplification; Drug resistance; N myc gene; Small cell lung carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIRUBICIN; MITOMYCIN C;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; ONCOGENE C MYB; PLACENTA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SMALL CELL; CISPLATIN; DRUG STABILITY; GENE AMPLIFICATION; GENES, MYC; HUMANS; LUNG NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029789859     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227598     Document Type: Article

References (19)

1. Nau MM, Brooks BJ, Carney DN, Gazdar AF, Baltey JF, Sausville EA, Minna JD: Human small cell lung cancers show amplification and expression of the N-wyc gene. Proc Natl Acad Sci USA 1986:83:1092-1096.
2. Brodcur GM, Secger RC, Schwab M, Varmus HE, Bishop JM: Amplification of N-/»>•<' in untreated human neuroblastomas correlated with advanced disease stage. Science 1984;224: 1121-1124.
3. Nisen PD, Zimmerman KA, Cotter SV, Gilbert F, Alt FW: Enhanced expression of the N-m.yc gene in Wilms’ tumor. Cancer Res I986;46: 6217-6222.
4. Secgcr RC, Brodcur GM, Sathcr H, Dalton A, Siegel SE, Wong KY, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N EngIJMed 1985;313:1111-1116.
5. Funa K, Steinholtz L, Nou E, Bergh J: Increased expression of N-myc in human small cell lung cancer biopsies predict lack of response to chemotherapy and poor prognosis. Am J Clin Pathol 1987;88:216-220.
6. Tsuda H, Shimosato Y, Upton MP, Yokota J, Terada M. Ohira M, Sugimura T, Hirohashi S: Retrospective study on amplification ofN-mrc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation. Lab Invest 1988;59:321-327.
7. Mizushima Y, Kashii T, Kobayashi M: Association between gene alteration and drug sensitivity in human lung carcinoma cell lines. Oncol Rep 1995;2:277-280.
8. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
9. Kashii T, Mizushima Y, Monno S, Nakagawa K, Kobayashi M: Gene analysis of K-.H-rrw, p53 and retinoblastoma susceptibility genes in human lung cancer cell lines by polymerase chain reaction single-strand conformation polymorphism method. J Cancer Res Clin Oncol 1994:120:143-148.
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocya-natc-phcnol-chloroform extraction. Anal Bio-chem 1987;162:156-159.
11. Sklar MD, Prochownik EV: Modulation of cis-platinum resistance in Friend crythrolcukcmia cells by c-myc. Cancer Res 1991;51:2118-2123.
12. Bungo M. Fujiwara Y. Kasahara K, Nakagawa K, Ohe Y. Sasaki Y. Irino S. Saijo N: Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: Relation to DNA damage and repair. Cancer Res 1990;50: 2549-2553.
13. Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T, Saijo N: The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP). Jpn J Cancer Res 1993:84:83-92.
14. Fujiwara Y, Sugimoto Y, Kasahara K, Bungo M, Yamakido M, Tew KD, Saijo N: Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn J Cancer Res 1990;81:527-535.
15. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N: Mctallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 1991;51:3237-3242.
16. Tcichcr BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A. Henncr WD, Emil F III: Characterization of a human squamous carcinoma cell line resistant to cis-diantmine-dichloroplatinum (II). Cancer Res 1987;47: 388-393.
17. Sklar MD: Increased resistance to cis-di-amminedichloroplatinum(II) in NIH3T3 cells transformed by ras oncogenes. Cancer Res 1988;48:793-797.
18. Nimi S, Nakagawa K, Yokota J, Tsunokawa Y, Nishio K, Terashima Y, Shibuya M, Terada M, Saijo N: Reistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-rrw genes. Br J Cancer 1991;63:237-241.
19. Grant CE, Valdimarsson G, Hipfner DR, Alm-quist KC, Cole SPC, Decley RG: Overcxpres-sion of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994:54:357-361.